Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18055865 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Eculizumab Therapy for Chronic Complement-Mediated Injury in Kidney Transplantation
Condition: Kidney; Complications, Allograft
Intervention: Drug: eculizumab

Indicates status has not been verified in more than two years